SCHEMBL456197

SCHEMBL456197

CCOC(=O)C(CC)(CC)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
TSHR P16473 1/20 0.44
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP4F2 P78329 2/20 0.42
CYP4A11 Q02928 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
HSD17B10 Q99714 1/20 0.40
PIN1 Q13526 1/20 0.40
PKM P14618 3/20 0.39
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27889242 0.98 MEN1 (0.47) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL30440649 0.98 MEN1 (0.47) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL8306724 0.98 MEN1 (0.47) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL1244565 0.87 MEN1 (0.54) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL5198071 0.87 MEN1 (0.47) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL3003335 0.86 MEN1 (0.42) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL23091475 0.85 MEN1 (0.52) MEN1KMT2ATSHRALDH1A1LMNA
Ammonia Solution, Strong SCHEMBL29049233 0.85 MEN1 (0.52) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL27889245 0.85 MEN1 (0.52) MEN1KMT2ATSHRALDH1A1LMNA
Iodide SCHEMBL10533617 0.85 MEN1 (0.52) MEN1KMT2ATSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119390574-A 1, 4-Fullerene C60Derivatives and process for preparing the same 吉林化工学院 2025-02-07 CN claimed
US-12113460-B2 Electrostatic machine system and method of operation C-Motive Technologies, Inc. (US) 2024-10-08 US claimed
CN-118620520-A Polyamide imide varnish cured at low temperature and preparation method and application thereof 宁波博雅聚力新材料科技有限公司 2024-09-10 CN claimed
US-11742779-B2 Electrostatic motor having fluid management features C-Motive Technologies, Inc. (US) 2023-08-29 US claimed
CN-112354566-B Barbituric acid-polymetallic oxygen cluster hybrid and preparation method thereof 中北大学 2023-04-21 CN claimed
EP-4085520-A1 ELECTROSTATIC MOTOR C-Motive Technologies Inc. (US) 2022-11-09 EP claimed
EP-4085521-A1 ELECTROSTATIC MOTOR HAVING FLUID MANAGEMENT FEATURES C-Motive Technologies Inc. (US) 2022-11-09 EP claimed
CN-114805647-A Catalyst composition for olefin polymerization and application thereof 北京肯佰恩科技发展有限公司 2022-07-29 CN claimed
CN-114605622-A Aliphatic polyester with malonic acid structure and preparation method and application thereof 苏州瀚海新材料有限公司 2022-06-10 CN claimed
EP-3973997-A1 MEMBRANE ACTIVE MOLECULES Branequest, Inc. (US) 2022-03-30 EP claimed
EP-3881425-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION C-Motive Technologies, Inc. (US) 2021-09-22 EP claimed
US-20210211069-A1 ELECTROSTATIC MOTOR HAVING FLUID MANAGEMENT FEATURES C-Motive Technologies, Inc. 2021-07-08 US claimed
WO-2020101796-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION C-Motive Technologies, Inc. (US) 2020-05-22 WO claimed
EP-3615084-A1 MEMBRANE ACTIVE MOLECULES Branequest, Inc. (US) 2020-03-04 EP claimed
WO-2018200412-A1 MEMBRANE ACTIVE MOLECULES BraneQuest, Inc. (US) 2018-11-01 WO claimed
US-20180303821-A1 MEMBRANE ACTIVE MOLECULES KNOWLEDGE PHARMACEUTICALS INC. 2018-10-25 US claimed
CN-104513330-B A kind of catalyst systems for olefin polymerization and its application 中国石油化工股份有限公司 2017-07-28 CN claimed
CN-106397199-A Synthetic method for intermediate diethyl diethylmalonate of barbiturate 厦门安普顿信息科技有限公司 2017-02-15 CN claimed
CN-104513327-B Olefin polymerization catalyst composition and applications thereof 中国石油化工股份有限公司 2017-02-15 CN claimed
US-6415614-B1 CONTROLLING VAPOR PRESSURE OF MIXTURE VISTEON GLOBAL TECHNOLOGIES, INC. 2002-07-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180303821-A1 MEMBRANE ACTIVE MOLECULES GABRP, GRIN3A, GRIN2A MEN1 4668/4885KMT2A 3080/4885TSHR 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.